SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Operating Liabilities
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Operating Liabilities of -$343.00 thousand for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2021-02-16
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in operating liabilities for the quarter ending 2020-12-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in operating liabilities for the quarter ending 2020-09-30 was -$297.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in operating liabilities for the quarter ending 2020-06-30 was -$46.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in operating liabilities for the quarter ending 2020-03-31 was -$87.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in operating liabilities for fiscal 2020 was -$489.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in operating liabilities for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Operating Liabilities 3 month | Increase (Decrease) in Operating Liabilities 6 month | Increase (Decrease) in Operating Liabilities 9 month | Increase (Decrease) in Operating Liabilities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | -$297.00K derived: sum of 2 quarters · filed 2021-02-16 | -$343.00K 10-Q · filed 2021-02-16 | -$430.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-09-30 | -$297.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | -$343.00K 10-Q · filed 2020-11-20 | -$430.00K derived: sum of 3 quarters · filed 2020-11-20 | -$565.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-06-30 | -$46.00K 10-Q/A · filed 2020-11-17 | -$133.00K derived: sum of 2 quarters · filed 2020-11-17 | -$268.00K derived: sum of 3 quarters · filed 2021-02-16 | -$403.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-03-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | -$222.00K derived: sum of 2 quarters · filed 2021-02-16 | -$357.00K derived: sum of 3 quarters · filed 2021-02-16 | -$489.00K 10-K · filed 2020-07-10 |
| 2019-12-31 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | -$270.00K derived: sum of 2 quarters · filed 2021-02-16 | -$402.00K 10-Q · filed 2021-02-16 | -$402.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | -$135.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | -$267.00K 10-Q · filed 2020-11-20 | -$267.00K derived: sum of 3 quarters · filed 2020-11-20 | -$267.00K derived: sum of 4 quarters · filed 2020-11-20 |
| 2019-06-30 | -$132.00K 10-Q/A · filed 2020-11-17 | -$132.00K derived: sum of 2 quarters · filed 2020-11-17 | -$132.00K derived: sum of 3 quarters · filed 2020-11-17 | -$132.00K derived: sum of 4 quarters · filed 2020-11-17 |
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | $0.00 derived: sum of 2 quarters · filed 2020-07-10 | $0.00 derived: sum of 3 quarters · filed 2020-07-10 | $0.00 10-K · filed 2020-07-10 |
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | $0.00 derived: sum of 2 quarters · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 | |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |